Observationa Study is a Prospective and Multi-institutional Observational Study.
NCT06952855 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5536
Last updated 2025-05-13
Summary
This observational study is a prospective, multi-institutional non intervention study to examine the prescription patterns, corresponding treatment effects and safety in routine clinical practice for patients prescribed for the treatment of gastroesophageal reflux disease.
Conditions
- Erosive Reflux Disease
- Heartburn
- Acid Regurgitation
Sponsors & Collaborators
-
Jeil Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-01
- Primary Completion
- 2025-04-23
- Completion
- 2025-04-23
Countries
- South Korea
More Related Trials
-
Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea
NCT01018160 ·Status: COMPLETED
-
A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)
NCT00216489 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
NCT02615184 ·Status: TERMINATED ·Phase: PHASE2
-
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
NCT02556021 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period
NCT00614536 ·Status: COMPLETED
-
Efficacy and Safety of DLBS2411 in the Management of GERD
NCT03367195 ·Status: TERMINATED ·Phase: PHASE3
-
Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study
NCT00963144 ·Status: COMPLETED
-
Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.
NCT01601379 ·Status: COMPLETED
-
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
NCT05753748 ·Status: RECRUITING ·Phase: NA
-
The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients
NCT02149914 ·Status: UNKNOWN ·Phase: NA
-
Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease
NCT03436914 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease
NCT01400945 ·Status: COMPLETED ·Phase: PHASE3
-
Prevalence of Hiatus Hernia in Gastro-Esophageal Reflux Disease Patients Underwent Upper Endoscopy
NCT06155851 ·Status: NOT_YET_RECRUITING
-
Individualized Diagnosis and Treatment of Extraesophageal Reflux in Patients With Chronic Cough
NCT04984304 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial
NCT01888549 ·Status: COMPLETED ·Phase: NA
-
Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication
NCT02934152 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis
NCT00255151 ·Status: COMPLETED ·Phase: PHASE3
-
STRETTA ,Radio Frequency Ablation (RFA) v/s Sham Therapy for the Treatment of Refractory GERD
NCT02935881 ·Status: UNKNOWN ·Phase: PHASE3
-
Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment
NCT00857597 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)
NCT00236392 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Extraesophageal Reflux on Inferior Nasal Turbinates Hypertrophy
NCT04581174 ·Status: COMPLETED ·Phase: NA
-
Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity
NCT00884247 ·Status: COMPLETED
-
A Prospective, Observational Study of the PPI Non-responder
NCT03282084 ·Status: WITHDRAWN
-
Lesogaberan in Chinese Patients With Refractory Reflux Symptoms
NCT02818309 ·Status: UNKNOWN ·Phase: PHASE2